Physician

Ramzi Haddadin, M.D.

According to 2025 Medicare claims, Ramzi Haddadin, M.D. (NPI: 1902844848) practices pulmonary disease in the Beckley, WV market, with the plurality of this provider's patient population coming from Raleigh, WV. This provider's primary affiliated billing organization is APPALACHIAN REGIONAL HEALTHCARE, INC (NPI: 1477510162; TIN: 520795508) and primary practice location at 25801-3142. Haddadin is affiliated with the ACO West Virginia (ACO ID: A3563) and Main Street Rural Health Sycamore ACO LLC (ACO ID: A5403), participating under the MSSP model.

Haddadin's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 438 traditional Medicare patients, billed 1,806 HCPCS/CPT codes, and received $128,608 in Medicare payments. The top billing code was 99222 (Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes). Part D data shows 3,104 prescription claims across 425 beneficiaries totaling $1,482,871 in drug costs, led by Trelegy Ellipta (Fluticasone/Umeclidin/Vilanter). DME data shows 1,458 claims. Open Payments data shows 63 records totaling $8,953. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has fallen sharply in recent years, from $349,861 to $128,608. In contrast, Part D prescription costs have moved sharply higher in recent years, from $657,438 to $1,482,871. For DME billing, reported payments declined steadily, from $344,963 to $111,635.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	857	5,595	$349,861
2016	902	5,677	$354,458
2017	926	5,865	$363,647
2018	982	5,895	$400,007
2019	893	4,945	$326,716
2020	705	3,996	$269,522
2021	550	2,350	$191,865
2022	583	2,140	$166,741
2023	490	1,855	$151,851
2024	438	1,806	$128,608

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	340	2,223	$657,438
2016	364	2,530	$730,045
2017	372	2,558	$856,508
2018	403	2,477	$829,160
2019	374	2,384	$891,658
2020	320	1,924	$732,532
2021	319	1,884	$911,880
2022	359	2,309	$1,272,526
2023	364	2,745	$1,466,634
2024	425	3,104	$1,482,871

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	470	2,733	$361,821
2016	641	3,263	$302,914
2017	504	2,571	$203,875
2018	607	2,994	$269,699
2019	739	3,560	$355,237
2020	604	3,078	$366,117
2021	573	2,892	$295,930
2022	482	2,380	$198,284
2023	338	2,009	$177,566
2024	309	1,458	$115,755

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99222	Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes	67	76	$105
99232	Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes	133	530	$62
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	212	324	$57
94060	Test to measure expiratory airflow and volume changes before and after medication administration	102	112	$8
94729	Test to examine how well the lungs exchange gases	102	112	$7

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	574	19,980	$417,887
Breztri Aerosphere	Budesonide/Glycopyr/Formoterol	208	7,641	$157,322
Glassia	Alpha-1-Proteinase Inhibitor	13	364	$150,303
Fasenra Pen	Benralizumab	25	1,316	$143,255
Nucala	Mepolizumab	30	840	$119,611

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
E0466	Home ventilator, any type, used with non-invasive interface, (e.g., mask, chest shell)	Y	N/R	58	$58,184
E1390	Oxygen concentrator, single delivery port, capable of delivering 85 percent or greater oxygen concentration at the prescribed flow rate	Y	58	387	$30,092
E1392	Portable oxygen concentrator, rental	Y	17	135	$4,679
A7030	Full face mask used with positive airway pressure device, each	N	20	36	$3,241
Q0513	Pharmacy dispensing fee for inhalation drug(s); per 30 days	N	33	129	$3,063

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	63	$8,953	AstraZeneca Pharmaceuticals LP
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Ramzi Haddadin, M.D.?

Tedicare shows public-source Medicare data for Ramzi Haddadin, M.D. (NPI 1902844848), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Ramzi Haddadin, M.D. have ACO affiliation data?

Ramzi Haddadin, M.D. is shown with ACO affiliation data for ACO West Virginia (MSSP, ACO ID A3563) and Main Street Rural Health Sycamore ACO LLC (MSSP, ACO ID A5403).

What billing organization is linked to Ramzi Haddadin, M.D.?

Ramzi Haddadin, M.D. is linked to APPALACHIAN REGIONAL HEALTHCARE, INC (billing NPI 1477510162) in the available physician profile data.

Does Ramzi Haddadin, M.D. have Open Payments data?

Ramzi Haddadin, M.D. has 63 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.